Author

W. Kim

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 8 Immunology· 5 Bioengineering· 3 Biophysics· 3 Cell Biology· 3 Animal Behavior & Cognition· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 22 Organism:human· 13 Approach:statistical model· 9 Research Focus:cell type annotation· 8 Research Focus:host-pathogen & immune response· 6 Organism:mouse· 5 Assay:bulk RNA-seq· 4 Research Focus:chromatin & epigenetic regulation· 4

Frequent Co-Authors

A. J. Schmitz· 4 shared J. S. Turner· 4 shared M. K. Klebert· 4 shared R. M. Presti· 4 shared W. D. Middleton· 4 shared A. Haile· 3 shared J. Q. Zhou· 3 shared S. A. Teefey· 3 shared

Activity by Year

2018-2024 · peak 8/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersImmunology

A. J. Schmitz

Mutual co-authors in cluster

Author profile →

32 papers

Recent·Most cited

Pharmacology & ToxicologybioRxivAug 17, 2018

Computational drug repositioning of bortezomib to reverse metastatic effect of GALNT14 in lung cancer

O.-S. Kwon, H. Lee, H.-J. Kong…·H.-J. Cha

This study uses in silico drug repositioning to identify bortezomib as an inhibitor of GALNT14-driven lung cancer metastasis, validated through in vitro and in vivo experiments.

DOI 10.1038/s41388-020-1316-2

humanbulk RNA-seq

𝕏 PostBluesky

PhysiologybioRxivMay 23, 2018

Impact of Chronic Total Occlusion Lesion Length onSix-month Angiographic and 2-year Clinical Outcomes

J. Ahn, S.-W. Rha, B. Choi…·H. Yu

This study compares 6-month angiographic and 2-year clinical outcomes between long and short chronic total occlusion (CTO) lesions after successful DES PCI, finding higher repeat PCI rates in long CTO lesions.

DOI 10.1371/journal.pone.0198571

humanclinical cohort / trial

𝕏 PostBluesky